Australia seems to be punching above its weight on innovative biotech companies, from cultivated meat to printing human cells. Why?

Today Michael Thompson is joined by Stefan von Imhof from alternative investing platform Alts.co to look at why Australia's outperforming in biotech.

Fear & Greed Q+A: Join Sean Aylmer & Michael Thompson and the team as they answer questions on business, investing, economics, politics and more. If you have your own question, get in touch via our website, LinkedIn, Instagram or Facebook.